The FY2025 (Dec) proxy of Jade Biosciences names 20 peer companies for pay. Pay versus performance data of Jade Biosciences for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Kymera Therapeutics | ||
| Spyre Therapeutics | ||
| Lyell Immunopharma | ||
| Oruka Therapeutics | ||
| ACELYRIN, Inc. | Not disclosed | Not disclosed |
| Alumis | Not disclosed | Not disclosed |
| Apogee Therapeutics, Inc. | Not disclosed | Not disclosed |
| Astria Therapeutics, Inc. | Not disclosed | Not disclosed |
| CARGO Therapeutics, Inc. | Not disclosed | Not disclosed |
| Contineum Therapeutics, Inc. | Not disclosed | Not disclosed |
| Dianthus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Entrada Therapeutics | Not disclosed | Not disclosed |
| Janux Therapeutics | Not disclosed | Not disclosed |
| Kyverna Therapeutics, Inc. | Not disclosed | Not disclosed |
| Pliant Therapeutics, Inc. | Not disclosed | Not disclosed |
| Prime Medicine | Not disclosed | Not disclosed |
| Septerna Therapeutics, Inc. | Not disclosed | Not disclosed |
| Third Harmonic Bio, Inc. | Not disclosed | Not disclosed |
| Upstream Bio | Not disclosed | Not disclosed |
| Zenas BioPharma | Not disclosed | Not disclosed |
20 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.